1. Université de Lyon, F69000; INSERM, EVIR, U758, Human Virology Department, F-69007; Ecole Normale Supérieure de Lyon, F-69007; and Université Lyon 1, F-69007, Lyon, France.
2. CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Division of Innovative Therapies, 92265 Fontenay-aux-Roses, France.
3. INSERM U962 and University Paris Sud 11, CEA-iMETI, 92265 Fontenay-aux-Roses, France.
4. INSERM UMR-S 972, Université Paris Sud 11, 94270 Le Kremlin-Bicêtre, France.
5. Service d'Hématologie Clinique, 06202 CHU Besançon, France.
6. CEA, MIRCen, i2BM, 92265 Fontenay-aux-roses, France.
7. CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Division of Immunovirology, 92265 Fontenay-aux-Roses, France.
8. UMR E1, Université Paris Sud, 91400 Orsay, France.
9. Genetics Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215.